• Home
  • R&D

R&D

OliX Pipeline

  • Pipeline
  • OLX101A
  • OLX201A
  • OLX301A
  • OLX301D

To overcome limitations in stability and delivery and minimize siRNA’s toxicity, OliX concentrates on the development
of RNAi therapeutics for dermal, ophthalmic, pulmonary and liver diseases.